Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4I3E1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 105 | 109 | PF00656 | 0.564 |
CLV_NRD_NRD_1 | 208 | 210 | PF00675 | 0.705 |
CLV_NRD_NRD_1 | 343 | 345 | PF00675 | 0.458 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.531 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 343 | 345 | PF00082 | 0.399 |
CLV_PCSK_PC1ET2_1 | 142 | 144 | PF00082 | 0.531 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.722 |
CLV_PCSK_SKI1_1 | 256 | 260 | PF00082 | 0.378 |
DEG_SCF_FBW7_1 | 290 | 296 | PF00400 | 0.628 |
DOC_CKS1_1 | 290 | 295 | PF01111 | 0.637 |
DOC_CYCLIN_yCln2_LP_2 | 331 | 337 | PF00134 | 0.472 |
DOC_MAPK_MEF2A_6 | 327 | 335 | PF00069 | 0.420 |
DOC_MAPK_RevD_3 | 329 | 344 | PF00069 | 0.434 |
DOC_PP1_RVXF_1 | 336 | 343 | PF00149 | 0.564 |
DOC_PP2B_LxvP_1 | 235 | 238 | PF13499 | 0.488 |
DOC_PP2B_LxvP_1 | 331 | 334 | PF13499 | 0.486 |
DOC_PP4_FxxP_1 | 295 | 298 | PF00568 | 0.500 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.598 |
DOC_USP7_MATH_1 | 285 | 289 | PF00917 | 0.593 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.503 |
DOC_WW_Pin1_4 | 241 | 246 | PF00397 | 0.551 |
DOC_WW_Pin1_4 | 286 | 291 | PF00397 | 0.699 |
LIG_14-3-3_CanoR_1 | 102 | 111 | PF00244 | 0.346 |
LIG_14-3-3_CanoR_1 | 143 | 149 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 280 | 285 | PF00244 | 0.627 |
LIG_14-3-3_CanoR_1 | 82 | 92 | PF00244 | 0.444 |
LIG_Actin_WH2_2 | 159 | 177 | PF00022 | 0.455 |
LIG_Actin_WH2_2 | 247 | 262 | PF00022 | 0.423 |
LIG_CaM_IQ_9 | 268 | 283 | PF13499 | 0.485 |
LIG_eIF4E_1 | 263 | 269 | PF01652 | 0.380 |
LIG_FHA_1 | 181 | 187 | PF00498 | 0.508 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.494 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.447 |
LIG_FHA_2 | 242 | 248 | PF00498 | 0.500 |
LIG_FHA_2 | 272 | 278 | PF00498 | 0.576 |
LIG_GBD_Chelix_1 | 170 | 178 | PF00786 | 0.475 |
LIG_LIR_Apic_2 | 292 | 298 | PF02991 | 0.530 |
LIG_LIR_Gen_1 | 14 | 21 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 129 | 134 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 14 | 19 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 247 | 251 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 346 | 352 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 355 | 359 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.453 |
LIG_PTB_Apo_2 | 133 | 140 | PF02174 | 0.557 |
LIG_REV1ctd_RIR_1 | 129 | 139 | PF16727 | 0.453 |
LIG_SH2_STAP1 | 111 | 115 | PF00017 | 0.499 |
LIG_SH2_STAP1 | 263 | 267 | PF00017 | 0.434 |
LIG_SH2_STAT3 | 38 | 41 | PF00017 | 0.550 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 352 | 355 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.465 |
LIG_SH2_STAT5 | 99 | 102 | PF00017 | 0.456 |
LIG_SH3_1 | 351 | 357 | PF00018 | 0.543 |
LIG_SH3_3 | 121 | 127 | PF00018 | 0.466 |
LIG_SH3_3 | 181 | 187 | PF00018 | 0.461 |
LIG_SH3_3 | 287 | 293 | PF00018 | 0.655 |
LIG_SH3_3 | 351 | 357 | PF00018 | 0.605 |
LIG_TRFH_1 | 295 | 299 | PF08558 | 0.492 |
LIG_TRFH_1 | 58 | 62 | PF08558 | 0.466 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.556 |
MOD_CK1_1 | 24 | 30 | PF00069 | 0.555 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.640 |
MOD_CK2_1 | 19 | 25 | PF00069 | 0.584 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.511 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.622 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.424 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.471 |
MOD_GlcNHglycan | 318 | 321 | PF01048 | 0.464 |
MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.438 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.569 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.485 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.376 |
MOD_GSK3_1 | 285 | 292 | PF00069 | 0.553 |
MOD_GSK3_1 | 316 | 323 | PF00069 | 0.492 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.500 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.577 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.466 |
MOD_PIKK_1 | 11 | 17 | PF00454 | 0.435 |
MOD_PIKK_1 | 225 | 231 | PF00454 | 0.468 |
MOD_PIKK_1 | 37 | 43 | PF00454 | 0.499 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.664 |
MOD_PKA_2 | 259 | 265 | PF00069 | 0.434 |
MOD_Plk_1 | 107 | 113 | PF00069 | 0.605 |
MOD_Plk_1 | 180 | 186 | PF00069 | 0.479 |
MOD_Plk_1 | 263 | 269 | PF00069 | 0.444 |
MOD_Plk_2-3 | 159 | 165 | PF00069 | 0.607 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.439 |
MOD_Plk_4 | 50 | 56 | PF00069 | 0.484 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.510 |
MOD_ProDKin_1 | 241 | 247 | PF00069 | 0.542 |
MOD_ProDKin_1 | 286 | 292 | PF00069 | 0.695 |
TRG_DiLeu_BaEn_1 | 264 | 269 | PF01217 | 0.383 |
TRG_ENDOCYTIC_2 | 138 | 141 | PF00928 | 0.352 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.451 |
TRG_ER_diArg_1 | 194 | 197 | PF00400 | 0.632 |
TRG_ER_diArg_1 | 208 | 210 | PF00400 | 0.627 |
TRG_ER_diArg_1 | 342 | 344 | PF00400 | 0.413 |
TRG_Pf-PMV_PEXEL_1 | 200 | 204 | PF00026 | 0.722 |
TRG_Pf-PMV_PEXEL_1 | 276 | 281 | PF00026 | 0.496 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IA55 | Leptomonas seymouri | 51% | 75% |
A0A3Q8IQE0 | Leishmania donovani | 99% | 71% |
A4HGA7 | Leishmania braziliensis | 77% | 100% |
E9AZM8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q8K3 | Leishmania major | 89% | 100% |